Direct evidence that mitochondrial iron accumulation occurs in Friedreich ataxia

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Annals of Neurology

• Publication date

  1999-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/1531-8249(199905)45:5<673::AID-ANA20>3.0.CO;2-QPMID 10319894
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Respiratory deficiency due to loss of mitochondrial DNA in yeast lacking the frataxin homologue

  1997cited by this paper
• Frataxin gene of Friedreich's ataxia is targeted to mitochondria

  1997cited by this paper
• Studies of human, mouse and yeast homologues indicate a mitochondrial function for frataxin

  1997cited by this paper
• Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin.

  1997cited by this paper
• Deletion of the yeast homologue of the human gene associated with Friedreich's ataxia elicits iron accumulation in mitochondria

  1997cited by this paper
• Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes.

  1997cited by this paper
• Aconitase and mitochondrial iron–sulphur protein deficiency in Friedreich ataxia

  1997cited by this paper
• Friedreich's Ataxia: Autosomal Recessive Disease Caused by an Intronic GAA Triplet Repeat Expansion

  1996cited by this paper
• Leigh syndrome: Clinical features and biochemical and DNA abnormalities

  1996cited by this paper
• Immunocytochemical studies on the vimentin distribution and cell proliferation of fibroblasts in patients with Friedreich's ataxia.

  1993cited by this paper
• Measurement of the activity of individual respiratory chain complexes in isolated fibroblast mitochondria.

  1992cited by this paper
• Prevalence of hereditary ataxias and spastic paraplegias in Molise, a region of Italy

  1992cited by this paper
• mtDNA depletion with variable tissue expression: a novel genetic abnormality in mitochondrial diseases.

  1991cited by this paper
• Growth studies on fibroblasts of patients with autosomal recessive Friedreich's ataxia.

  1991cited by this paper
• Studies of cellular hypersensitivity to ionising radiation in Friedreich's ataxia.

  1982cited by this paper
• Friedreich's ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features.

  1981cited by this paper
• Pathology of the Heart in Friedreich's Ataxia: Review of the Literature and Report of One Case

  1976cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Alpha–lipoic acid supplementation improves pathological alterations in cellular models of Friedreich ataxia

  2025cites this paper
• E3 ligases and DUBs target ferroptosis: A potential therapeutic strategy for neurodegenerative diseases.

  2024cites this paper
• Genetic Determined Iron Starvation Signature in Friedreich's Ataxia

  2024cites this paper
• A new FRDA mouse model [Fxnnull:YG8s(GAA) > 800] with more than 800 GAA repeats

  2023cites this paper
• Friedreich's ataxia: new insights.

  2023cites this paper
• Long non-coding RNA TUG1 is downregulated in Friedreich’s ataxia

  2023cites this paper
• Omaveloxolone: an activator of Nrf2 for the treatment of Friedreich ataxia

  2023cites this paper
• Treatment and Management of Autosomal Recessive Cerebellar Ataxias: Current Advances and Future Perspectives.

  2022cites this paper
• Friedreich ataxia: clinical features and new developments.

  2022cites this paper
• Posttranslational regulation of mitochondrial frataxin and identification of compounds that increase frataxin levels in Friedreich’s ataxia

  2022cites this paper
• Iron-frataxin involved in the protective effect of quercetin against alcohol-induced liver mitochondrial dysfunction.

  2022cites this paper
• Mitochondrial targeting of potent nanoparticulated drugs in combating diseases

  2022cites this paper
• Down the Iron Path: Mitochondrial Iron Homeostasis and Beyond

  2021cites this paper
• A pathogenic role for histone H3 copper reductase activity in a yeast model of Friedreich’s ataxia

  2021cites this paper
• The Nrf2 induction prevents ferroptosis in Friedreich's Ataxia

  2020cites this paper
• Antiferroptotic Activity of Phenothiazine Analogues: A Novel Therapeutic Strategy for Oxidative Stress Related Disease.

  2020cites this paper
• The Involvement of Anti-Oxidative Response and Mitochondrial Dynamics in the Pathogenesis of Friedreich’s Ataxia: Relevance to the Development of Future Therapeutics

  2020cites this paper
• The NRF2 Signaling Network Defines Clinical Biomarkers and Therapeutic Opportunity in Friedreich’s Ataxia

  2020cites this paper
• Ferroptosis in Friedreich’s Ataxia: A Metal-Induced Neurodegenerative Disease

  2020cites this paper
• Patient‐reported outcomes in Friedreich’s ataxia after withdrawal from idebenone

  2019cites this paper
• Longitudinal evaluation of iron concentration and atrophy in the dentate nuclei in friedreich ataxia

  2019influential citation
• Friedreich ataxia- pathogenesis and implications for therapies.

  2019cites this paper
• New developments in pharmacotherapy for Friedreich ataxia

  2019cites this paper
• Metabolic Alterations in Inherited Cardiomyopathies

  2019cites this paper
• Ferroptosis as a Novel Therapeutic Target for Friedreich’s Ataxia

  2019cites this paper
• The Role of Iron in Friedreich’s Ataxia: Insights From Studies in Human Tissues and Cellular and Animal Models

  2019cites this paper
• Dimethyl fumarate dosing in humans increases frataxin expression: A potential therapy for Friedreich’s Ataxia

  2019cites this paper
• Title Inducible and reversible phenotypes in a novel mouse model of Friedreich ' s Ataxia

  2018influential citation
• Longitudinal dentate nuclei iron concentration and atrophy in Friedreich ataxia: IMAGE-FRDA

  2018cites this paper
• Phenothiazine antioxidants increase mitochondrial biogenesis and frataxin levels in Friedreich's ataxia cells.

  2018cites this paper
• The regulation of incorrect splicing of ISCU in hereditary myopathy with lactic acidosis

  2018cites this paper
• Progress in the treatment of Friedreich ataxia.

  2018cites this paper
• Identification of p38 MAPK as a novel therapeutic target for Friedreich’s ataxia

  2018cites this paper
• Lipophilic methylene blue analogues enhance mitochondrial function and increase frataxin levels in a cellular model of Friedreich's ataxia.

  2018cites this paper
• Inducible and reversible phenotypes in a novel mouse model of Friedreich’s Ataxia

  2017influential citation
• Iron Homeostasis in Neuron-Glia Interaction

  2017cites this paper
• Heterologous mitochondrial targeting sequences can deliver functional proteins into mitochondria.

  2016cites this paper
• Frataxin and the molecular mechanism of mitochondrial iron-loading in Friedreich's ataxia.

  2016cites this paper
• Vitamin K2 suppresses rotenone-induced microglial activation in vitro

  2016cites this paper
• Epigenetic mechanisms as key regulators in disease: Clinical implications

  2016cites this paper
• Chapter 13 – Friedreich Ataxia

  2016cites this paper
• Glia in Drosophila behavior

  2015cites this paper
• Identification of Novel Mutations and Molecular Pathways for Canine Neurodegeneration and Chondrodysplasia

  2015cites this paper
• Compartmentalization of iron between mitochondria and the cytosol and its regulation.

  2015cites this paper
• Sensorimotor skills in Fxn KO/Mck mutants deficient for frataxin in muscle.

  2015cites this paper
• Mitochondrial iron homeostasis and its dysfunctions in neurodegenerative disorders.

  2015cites this paper
• The interplay between iron accumulation, mitochondrial dysfunction, and inflammation during the execution step of neurodegenerative disorders

  2014cites this paper
• Rescue of the Friedreich Ataxia Knockout Mutation in Transgenic Mice Containing an FXN-EGFP Genomic Reporter

  2014cites this paper
• Mitochondrial iron-sulfur protein biogenesis and human disease.

  2014cites this paper
• Role of ISCU in development of mitochondrial myopathy

  2014cites this paper
• The role of frataxin in fission yeast iron metabolism: implications for Friedreich's ataxia.

  2014cites this paper
• A 7-year-old girl with hypertrophic cardiomyopathy and progressive scoliosis.

  2014cites this paper
• Cerebellar pathology in Friedreich's ataxia: Atrophied dentate nuclei with normal iron content

  2014cites this paper
• Transition of Thalassaemia and Friedreich ataxia from fatal to chronic diseases.

  2014cites this paper
• The Presence of Multiple Cellular Defects Associated with a Novel G50E Iron-Sulfur Cluster Scaffold Protein (ISCU) Mutation Leads to Development of Mitochondrial Myopathy*

  2014cites this paper
• Biochemical and biophysical methods for studying mitochondrial iron metabolism.

  2014cites this paper
• HFE p.C282Y heterozygosity is associated with earlier disease onset in Friedreich ataxia

  2014cites this paper
• Genotype and phenotype characterisation of Friedreich ataxia mouse models and cells

  2013cites this paper
• A Dynamic Model of the Proteins that Form the Initial Iron-Sulfur Cluster Biogenesis Machinery in Yeast Mitochondria

  2013cites this paper
• Iron Metabolism and Related Disorders

  2013cites this paper
• Clinical neurogenetics: friedreich ataxia.

  2013cites this paper
• Pharmacological Screening Using an FXN-EGFP Cellular Genomic Reporter Assay for the Therapy of Friedreich Ataxia

  2013cites this paper
• Iron-sulfur cluster synthesis, iron homeostasis and oxidative stress in Friedreich ataxia.

  2013cites this paper
• compared to molecules involved in iron metabolism and hemoglobinization expression in Friend cells: characterization of frataxin expression Erythroid differentiation and protoporphyrin IX down-regulate frataxin

  2013cites this paper
• Co‐enzyme Q10 and idebenone use in Friedreich's ataxia

  2013cites this paper
• Co-enzyme Q 10 and idebenone use in Friedreich ’ s ataxia

  2013cites this paper
• implications Selective iron chelation in Friedreich ataxia. Biological and clinical

  2012cites this paper
• DNA triplex structures in neurodegenerative disorder, Friedreich’s ataxia

  2012cites this paper
• Iron dysregulation in movement disorders.

  2012cites this paper
• A Review of Friedreich Ataxia Clinical Trial Results

  2012cites this paper
• Triple Repeat Diseases of the Nervous Systems

  2012cites this paper
• Neurobiology of Disease

  2012cites this paper
• Idebenone in Friedreich ataxia cardiomyopathy-results from a 6-month phase III study (IONIA).

  2011cites this paper
• Neurological Disorders Associated with Iron Misdistribution: The Therapeutic Potential of Siderophores

  2011cites this paper
• Genetic Models of Cerebellar Dysfunction

  2011cites this paper
• Mesenchymal Stem Cells Restore Frataxin Expression and Increase Hydrogen Peroxide Scavenging Enzymes in Friedreich Ataxia Fibroblasts

  2011cites this paper
• A phase 3, double-blind, placebo-controlled trial of idebenone in friedreich ataxia.

  2010cites this paper
• Defects in Mitochondrial Axonal Transport and Membrane Potential without Increased Reactive Oxygen Species Production in a Drosophila Model of Friedreich Ataxia

  2010cites this paper
• Altered lipid metabolism in a Drosophila model of Friedreich's ataxia

  2010cites this paper
• Frataxin interacts with Isu1 through a conserved tryptophan in its beta-sheet.

  2010cites this paper
• Frataxin interacts with Isu 1 through a conserved tryptophan in its b-sheet

  2009cites this paper
• Chelation therapy for neurodegenerative diseases

  2009cites this paper
• NOVEL SYNCHROTRON-BASED ANALYSES OF METAL PATHOLOGY IN FRIEDREICH'S ATAXIA

  2009influential citation
• SYNAPTIC PLASTICITY AND THE NEUROBIOLOGICAL BASES OF LEARNING AND MEMORY

  2009cites this paper
• Medicinal inorganic chemistry approaches to passivation and removal of aberrant metal ions in disease.

  2009cites this paper
• DNA methylation in intron 1 of the frataxin gene is related to GAA repeat length and age of onset in Friedreich ataxia patients

  2008cites this paper
• Regression of symptoms after selective iron chelation therapy in a case of neurodegeneration with brain iron accumulation

  2008cites this paper
• Intracellular Iron Transport and Storage: From Molecular Mechanisms to Health Implications

  2008cites this paper
• MR‐spectroscopic findings in juvenile‐onset Huntington's disease

  2008cites this paper
• Protection against Hydrogen Peroxide-Mediated Cytotoxicity in Friedreich's Ataxia Fibroblasts Using Novel Iron Chelators of the 2-Pyridylcarboxaldehyde Isonicotinoyl Hydrazone Class

  2008cites this paper
• Focal childhood‐onset, action induced primary hip dystonia treated with pallidal deep brain stimulation

  2008cites this paper
• Urinary isoprostanes in Friedreich ataxia: Lack of correlation with disease features

  2008cites this paper
• Neurological effects of recombinant human erythropoietin in Friedreich's ataxia: A clinical pilot trial

  2008cites this paper
• Protection Against Hydrogen Peroxide-Mediated Cytotoxicity in Friedreich’s Ataxia Fibroblasts using Novel Iron Chelators of the PCIH

  2008cites this paper
• Selective iron chelation in Friedreich ataxia: biologic and clinical implications.

  2007cites this paper
• The chemical form of mitochondrial iron in Friedreich's ataxia.

  2007cites this paper
• Mitochondrial involvement in genetically determined transition metal toxicity I. Iron toxicity.

  2006cites this paper
• Iron dysregulation in Friedreich ataxia.

  2006cites this paper
• In vitro Study Involving the Comparative Effect of Heavy Metal Ions on Antioxidant Enzymes Activity and Lipid Peroxide Levels in Human Erythrocytes

  2006cites this paper
• Autosomal recessive cerebellar ataxias

  2006cites this paper